ORIENT-12 Study demonstrates adding sintilimab to gemcitabine/platinum has clinical benefit
In 10 years, COVID-19 could be ‘just the sniffles’
25 May 2021Q and A: 21st century stroke prevention strategies
25 May 2021ORIENT-12 Study demonstrates adding sintilimab to gemcitabine/platinum has clinical benefit
Adding sintilimab to a regimen of gemcitabine and platinum demonstrates clinical benefit over gemcitabine and platinum alone as first-line therapy in patients with locally advanced or metastatic squamous cell non-small cell lung cancer, according to a study published in the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer.
